Literature DB >> 29042463

Need to Reclassify Etiologies of ESRD on the CMS 2728 Medical Evidence Report.

Bryan M Tucker1, Barry I Freedman2.   

Abstract

Entities:  

Keywords:  Centers for Medicare and Medicaid Services (U.S.); Chronic; Documentation; ESRD; Epidemiology and outcomes; Humans; Kidney Failure; Medicaid; Medical Records; Medicare; Registries; Renal Replacement Therapy; United States; clinical epidemiology; clinical nephrology; diabetic nephropathy; hypertension; renal dialysis

Mesh：

Year:  2017        PMID： 29042463      PMCID： PMC5967672          DOI： 10.2215/CJN.08310817

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

1.  CMS 2728: what good is it?

Authors:  Paul W Eggers
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-07       Impact factor: 8.237

2.  Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

Authors:  J Bradley Layton; Susan L Hogan; Caroline E Jennette; Barbara Kenderes; Jenna Krisher; J Charles Jennette; William M McClellan
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

3.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

4.  Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis.

Authors:  L Zarif; A Covic; S Iyengar; A R Sehgal; J R Sedor; J R Schelling
Journal:  Nephrol Dial Transplant       Date:  2000-11       Impact factor: 5.992

5.  Diagnosis of hypertensive end-stage renal disease: effect of patient's race.

Authors:  T V Perneger; P K Whelton; M J Klag; K A Rossiter
Journal:  Am J Epidemiol       Date:  1995-01-01       Impact factor: 4.897

6.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

7.  Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Authors:  Kai-Uwe Eckardt; Seth L Alper; Corinne Antignac; Anthony J Bleyer; Dominique Chauveau; Karin Dahan; Constantinos Deltas; Andrew Hosking; Stanislav Kmoch; Luca Rampoldi; Michael Wiesener; Matthias T Wolf; Olivier Devuyst
Journal:  Kidney Int       Date:  2015-03-04       Impact factor: 10.612

8.  A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.

Authors:  Carolin E Sadowski; Svjetlana Lovric; Shazia Ashraf; Werner L Pabst; Heon Yung Gee; Stefan Kohl; Susanne Engelmann; Virginia Vega-Warner; Humphrey Fang; Jan Halbritter; Michael J Somers; Weizhen Tan; Shirlee Shril; Inès Fessi; Richard P Lifton; Detlef Bockenhauer; Sherif El-Desoky; Jameela A Kari; Martin Zenker; Markus J Kemper; Dominik Mueller; Hanan M Fathy; Neveen A Soliman; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

9.  Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center.

Authors:  Christina M Yuan; Robert Nee; Kevin A Ceckowski; Kendral R Knight; Kevin C Abbott
Journal:  Clin Kidney J       Date:  2016-12-22
  9 in total
  3 in total

Review 1.  Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.

Authors:  Alejandra M Mena-Gutierrez; Amber M Reeves-Daniel; Colleen L Jay; Barry I Freedman
Journal:  Transplantation       Date:  2020-01       Impact factor: 4.939

2.  Predictors of kidney function recovery among incident ESRD patients.

Authors:  Maria Santos; Huiying Yin; Diane Steffick; Rajiv Saran; Michael Heung
Journal:  BMC Nephrol       Date:  2021-04-21       Impact factor: 2.388

3.  Early Change in Platelet Count and MPV Levels of Patients Who Received Hemodialysis for the First Time: Mogadishu Somalia Experience.

Authors:  Oznur Sari; Ahmed Muhammad Bashir
Journal:  Int J Clin Pract       Date:  2022-06-30       Impact factor: 3.149
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.